Syngenta takeover likely to be approved
Syngenta AG Chairman Michel Demare said he expects only a “few” concessions would be needed to get regulatory approval for ChinaNational Chemical Corp’s $43 billion takeover of the Swiss maker of agrochemical and seeds company.
“The overlap is extremely small,” Demare said at the World Economic Forum in Davos.
“There’s a fewmarket concessions that will have to be made, but nothing that will fundamentally change the business model of Syngenta,” he added.
The deal has faced delays as authorities, who are concerned the acquisition might raise prices or reduce choice for crop-protection products sold to farmers, requested more information from the companies.
ChemChina already owns Israeli-based generic agrochemical maker Adama.
The EU antitrust review has been extended until April 12 to allow sufficient time to discuss remedy proposals that have been submitted.
The transaction is one of a trio of mega-deals reshaping the global agrochemicals industry.
Regulators are concerned that the industry is a very concentrated sector and that farmers need to have a choice of seeds and cropprotection products.
A visitor looks at a smartphone by Huawei Technologies Co Ltd at an international telecoms exhibition in Beijing. Huawei sold 139 million handsets in 2016, up 29 percent from the previous year.
CHINA DAILY (ISSN 07486154) is published daily except weekends by China Daily USA, 1500 Broadway, Suite 2800, New York, NY 10036. Periodical postage paid at New York, NY and additional mailing offices. POSTMASTER: Send address changes to CHINA DAILY USA, 1500 Broadway, Suite 2800, New York, NY 10036.